echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The medical insurance "green channel" of Chinese medicine has been opened up!

    The medical insurance "green channel" of Chinese medicine has been opened up!

    • Last Update: 2022-01-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    A large wave of TCM medical insurance preferential policy dividends is released: general TCM medical service items can continue to be paid by item, TCM institutions can temporarily not implement DRG payment, and TCM decoction pieces can continue to be added to the policy of 25%.
    .
    .
     
    On December 30, the National Medical Insurance Administration and the State Administration of Traditional Chinese Medicine jointly issued the "Guiding Opinions on Medical Insurance Supporting the Inheritance and Innovative Development of Traditional Chinese Medicine" (hereinafter referred to as the "Opinions").
    It will receive strong support from medical insurance, and enjoy the particularity of the development of Chinese medicine in terms of the scope of medical insurance payment and payment policy
    .
     
    Among them, general TCM medical service items can continue to be paid on a per-item basis, TCM institutions may not implement DRG payment for the time being, and TCM decoction pieces will continue to be added to the 25% policy, which makes a large group of western medicine manufacturers who are suffering from a cost control crisis enviable
    .
     
    Affected by this favorable policy, the stock prices of relevant listed Chinese medicine companies early today will be the best farewell for the last day of 2021 with different increases
    .
    As of 11:30 on December 31, 2021, Beijing time, many Chinese medicine stocks have reached their daily limit
    .
     
      The "Opinions" are based on the implementation of the previous two policies and the specific implementation at the level of medical insurance.
    These two policies are the "Opinions of the Central Committee of the Communist Party of China and the State Council on Promoting the Inheritance and Innovative Development of Traditional Chinese Medicine" and the "Opinions of the General Office of the State Council on Accelerating the Characteristics of Traditional Chinese Medicine".
    "Several Policy Measures for Development" were released on November 23, 2019 and January 22, 2021.
    From the context of the development of these three policies, it is not difficult to see that Chinese medicine is from top to bottom, from macro to micro, and from the system.
    At the local level, policy dividends are being released step by step
    .
     
      The "Opinions" is divided into six parts and a total of 15 articles.
    Among them, the benefits of Chinese medicine are reflected in the fixed-point inclusion of medical insurance, the price of Chinese medicine services, the scope of medical insurance payment, and the payment policy
    .
     
      Among them, the "Opinions" clearly pointed out that general TCM medical service items can continue to be paid by item, and TCM medical institutions may temporarily not implement DRG payment.
    For areas that have implemented DRG and disease-based payment, appropriately increase TCM medical institutions and TCM diseases.
    The coefficients and scores of these categories fully reflect the characteristics and advantages of traditional Chinese medicine services
    .
     
      As the current medical insurance payment reform is gradually shifting from the project system to the prepayment system, and the coexistence of multiple payment methods such as disease type, DRG/DIP, etc.
    , according to the characteristics of Chinese medicine, the policy of continuing to pay by project and not implementing DRG payment for the time being can be It is said that a separate "safe haven" has been opened, which is very beneficial to the development of Chinese medicine
    .
     
      According to the Fourteenth Five-Year Plan and the three-year action plan, by the end of 2024, all coordinated areas across the country will carry out the DRG/DIP payment method reform; by the end of 2025, the DRG/DIP payment method will cover all eligible medical institutions that provide hospitalization services.
    Basically achieve full coverage of disease types and medical insurance funds
    .
    Among them, the comprehensive coverage of disease types (in principle, 90%), the annual progress should be no less than 70%, 80%, and 90% respectively.
    The start-up area in 2024 must be completed within two years
    .
    Encourage the enrollment rate to reach more than 90%; after that, a list of 32 DRG/DIP paid demonstration sites was announced
    .
     
      There is also a special payment policy for the dominant diseases of traditional Chinese medicine
    .
     
      The "Opinions" can pay per bed day for the dominant Chinese medicine diseases that require long-term hospitalization, such as rehabilitation medical treatment and tranquility treatment
    .
    Explore the long-term treatment cycle, controllable risks, and need continuous treatment of TCM diseases, carry out day TCM medical services, implement disease-based payment, reasonably determine the payment standard, and the country will uniformly formulate a list of disease types in day wards
    .
    For the compact county medical community led by traditional Chinese medical institutions, the total budget is appropriately tilted
    .
     
      The "Opinions" clarified that public medical institutions purchase Chinese herbal medicines from formal channels, and sell them in strict accordance with the actual purchase price plus no more than 25%
    .
    Correspondingly, Western medicines and consumables have already implemented zero-addition, which is in sharp contrast
    .
    The "Opinions" also encourage the inclusion of traditional Chinese medicine formula granules purchased by public medical institutions into online transactions on the provincial centralized pharmaceutical procurement platform to promote openness and transparency of transactions
    .
     
      In addition, with regard to the medical insurance catalog, the adjustment authority of the national version of the catalog has long been withdrawn to the National Bureau, and the original local supplements will soon be digested.
    However, the local medical insurance department still retains the adjustment authority of ethnic medicine, medical preparations and traditional Chinese medicine
    .
     
      The "Opinions" clearly pointed out that all localities should include eligible ethnic medicines, traditional Chinese medicine preparations in medical institutions and Chinese herbal medicines into the scope of local medical insurance payments according to procedures according to fund affordability and clinical needs, and establish a dynamic adjustment mechanism
    .
     
    Chinese herbal medicines   that comply with the "Prescription Management Measures" and the " Management Standards of Chinese Herbal Medicines in Hospitals " but exceed the usual dose prescribed in the "Pharmaccopoeia of the People's Republic of China" will be included in the scope of medical insurance payment
    .
    It can be said that as far as possible , Chinese medicine- related products and services are included in the scope of payment, which greatly enhances the development space of Chinese medicine
    .
     
      In recent years, with the legislation of the "Traditional Chinese Medicine Law", the "Opinions of the Central Committee of the Communist Party of China and the State Council on Promoting the Inheritance and Innovative Development of Traditional Chinese Medicine" and the "Several Policy Measures of the General Office of the State Council on Accelerating the Development of Traditional Chinese Medicine", the Chinese medicine industry It has been highly valued by the country
    .
    The outstanding performance of Chinese medicine during the new crown pneumonia epidemic has also won the recognition of the whole society
    .
     
      At the same time, Chinese patent medicines have gradually entered the scope of mass procurement following the pace of chemical medicines
    .
     
      On December 27th, Hubei led the 19 provinces leading Chinese patent medicine inter-provincial alliance and announced the results of the centralized procurement of Chinese patent medicines
    .
    A total of 157 companies and 182 products in the 17 product groups of the procurement catalog participated in the quotation, with a procurement scale of nearly 10 billion yuan
    .
    In the end, 97 companies and 111 products were selected, with a selection rate of 62%.
    The average price of the selection dropped by 42.
    27%, and the largest drop was 82.
    63%
    .
    According to the calculation of the annual demand of the 19 provincial alliances, it is estimated that more than 2.
    6 billion yuan of drug costs can be saved each year
    .
      A large wave of TCM medical insurance preferential policy dividends is released: general TCM medical service items can continue to be paid by item, TCM institutions can temporarily not implement DRG payment, and TCM decoction pieces can continue to be added to the policy of 25%.
    .
    .
     
      On December 30, the National Medical Insurance Administration and the State Administration of Traditional Chinese Medicine jointly issued the "Guiding Opinions on Medical Insurance Supporting the Inheritance and Innovative Development of Traditional Chinese Medicine" (hereinafter referred to as the "Opinions").
    It will receive strong support from medical insurance, and enjoy the particularity of the development of Chinese medicine in terms of the scope of medical insurance payment and payment policy
    .
     
      Among them, general TCM medical service items can continue to be paid on a per-item basis, TCM institutions may not implement DRG payment for the time being, and TCM decoction pieces will continue to be added to the 25% policy, which makes a large group of western medicine manufacturers who are suffering from a cost control crisis enviable
    .
     
      Affected by this favorable policy, the stock prices of relevant listed Chinese medicine companies early today will be the best farewell for the last day of 2021 with different increases
    .
    As of 11:30 on December 31, 2021, Beijing time, many Chinese medicine stocks have reached their daily limit
    .
     
      The "Opinions" are based on the implementation of the previous two policies and the specific implementation at the level of medical insurance.
    These two policies are the "Opinions of the Central Committee of the Communist Party of China and the State Council on Promoting the Inheritance and Innovative Development of Traditional Chinese Medicine" and the "Opinions of the General Office of the State Council on Accelerating the Characteristics of Traditional Chinese Medicine".
    "Several Policy Measures for Development" were released on November 23, 2019 and January 22, 2021.
    From the context of the development of these three policies, it is not difficult to see that Chinese medicine is from top to bottom, from macro to micro, and from the system.
    At the local level, policy dividends are being released step by step
    .
     
      The "Opinions" is divided into six parts and a total of 15 articles.
    Among them, the benefits of Chinese medicine are reflected in the fixed-point inclusion of medical insurance, the price of Chinese medicine services, the scope of medical insurance payment, and the payment policy
    .
     
      Among them, the "Opinions" clearly pointed out that general TCM medical service items can continue to be paid by item, and TCM medical institutions may temporarily not implement DRG payment.
    For areas that have implemented DRG and disease-based payment, appropriately increase TCM medical institutions and TCM diseases.
    The coefficients and scores of these categories fully reflect the characteristics and advantages of traditional Chinese medicine services
    .
     
      As the current medical insurance payment reform is gradually shifting from the project system to the prepayment system, and the coexistence of multiple payment methods such as disease type, DRG/DIP, etc.
    , according to the characteristics of Chinese medicine, the policy of continuing to pay by project and not implementing DRG payment for the time being can be It is said that a separate "safe haven" has been opened, which is very beneficial to the development of Chinese medicine
    .
     
      According to the Fourteenth Five-Year Plan and the three-year action plan, by the end of 2024, all coordinated areas across the country will carry out the DRG/DIP payment method reform; by the end of 2025, the DRG/DIP payment method will cover all eligible medical institutions that provide hospitalization services.
    Basically achieve full coverage of disease types and medical insurance funds
    .
    Among them, the comprehensive coverage of disease types (in principle, 90%), the annual progress should be no less than 70%, 80%, and 90% respectively.
    The start-up area in 2024 must be completed within two years
    .
    Encourage the enrollment rate to reach more than 90%; after that, a list of 32 DRG/DIP paid demonstration sites was announced
    .
     
      There is also a special payment policy for the dominant diseases of traditional Chinese medicine
    .
     
      The "Opinions" can pay per bed day for the dominant Chinese medicine diseases that require long-term hospitalization, such as rehabilitation medical treatment and tranquility treatment
    .
    Explore the long-term treatment cycle, controllable risks, and need continuous treatment of TCM diseases, carry out day TCM medical services, implement disease-based payment, reasonably determine the payment standard, and the country will uniformly formulate a list of disease types in day wards
    .
    For the compact county medical community led by traditional Chinese medical institutions, the total budget is appropriately tilted
    .
     
      The "Opinions" clarified that public medical institutions purchase Chinese herbal medicines from formal channels, and sell them in strict accordance with the actual purchase price plus no more than 25%
    .
    Correspondingly, Western medicines and consumables have already implemented zero-addition, which is in sharp contrast
    .
    The "Opinions" also encourage the inclusion of traditional Chinese medicine formula granules purchased by public medical institutions into online transactions on the provincial centralized pharmaceutical procurement platform to promote openness and transparency of transactions
    .
     
      In addition, with regard to the medical insurance catalog, the adjustment authority of the national version of the catalog has long been withdrawn to the National Bureau, and the original local supplements will soon be digested.
    However, the local medical insurance department still retains the adjustment authority of ethnic medicine, medical preparations and traditional Chinese medicine
    .
     
      The "Opinions" clearly pointed out that all localities should include eligible ethnic medicines, traditional Chinese medicine preparations in medical institutions and Chinese herbal medicines into the scope of local medical insurance payments according to procedures according to fund affordability and clinical needs, and establish a dynamic adjustment mechanism
    .
     
    Chinese herbal medicines   that comply with the "Prescription Management Measures" and the " Management Standards of Chinese Herbal Medicines in Hospitals " but exceed the usual dose prescribed in the "Pharmaccopoeia of the People's Republic of China" will be included in the scope of medical insurance payment
    .
    It can be said that as far as possible , Chinese medicine- related products and services are included in the scope of payment, which greatly enhances the development space of Chinese medicine
    .
     
      In recent years, with the legislation of the "Traditional Chinese Medicine Law", the "Opinions of the Central Committee of the Communist Party of China and the State Council on Promoting the Inheritance and Innovative Development of Traditional Chinese Medicine" and the "Several Policy Measures of the General Office of the State Council on Accelerating the Development of Traditional Chinese Medicine", the Chinese medicine industry It has been highly valued by the country
    .
    The outstanding performance of Chinese medicine during the new crown pneumonia epidemic has also won the recognition of the whole society
    .
     
      At the same time, Chinese patent medicines have gradually entered the scope of mass procurement following the pace of chemical medicines
    .
     
      On December 27th, Hubei led the 19 provinces leading Chinese patent medicine inter-provincial alliance and announced the results of the centralized procurement of Chinese patent medicines
    .
    A total of 157 companies and 182 products in the 17 product groups of the procurement catalog participated in the quotation, with a procurement scale of nearly 10 billion yuan
    .
    In the end, 97 companies and 111 products were selected, with a selection rate of 62%.
    The average price of the selection dropped by 42.
    27%, and the largest drop was 82.
    63%
    .
    According to the calculation of the annual demand of the 19 provincial alliances, it is estimated that more than 2.
    6 billion yuan of drug costs can be saved each year
    .
      A large wave of TCM medical insurance preferential policy dividends is released: general TCM medical service items can continue to be paid by item, TCM institutions can temporarily not implement DRG payment, and TCM decoction pieces can continue to be added to the policy of 25%.
    .
    .
     
      On December 30, the National Medical Insurance Administration and the State Administration of Traditional Chinese Medicine jointly issued the "Guiding Opinions on Medical Insurance Supporting the Inheritance and Innovative Development of Traditional Chinese Medicine" (hereinafter referred to as the "Opinions").
    It will receive strong support from medical insurance, and enjoy the particularity of the development of Chinese medicine in terms of the scope of medical insurance payment and payment policy
    .
    Medicine Medicine Medicine
     
      Among them, general TCM medical service items can continue to be paid on a per-item basis, TCM institutions may not implement DRG payment for the time being, and TCM decoction pieces will continue to be added to the 25% policy, which makes a large group of western medicine manufacturers who are suffering from a cost control crisis enviable
    .
     
      Affected by this favorable policy, the stock prices of relevant listed Chinese medicine companies early today will be the best farewell for the last day of 2021 with different increases
    .
    As of 11:30 on December 31, 2021, Beijing time, many Chinese medicine stocks have reached their daily limit
    .
     
      The "Opinions" are based on the implementation of the previous two policies and the specific implementation at the level of medical insurance.
    These two policies are the "Opinions of the Central Committee of the Communist Party of China and the State Council on Promoting the Inheritance and Innovative Development of Traditional Chinese Medicine" and the "Opinions of the General Office of the State Council on Accelerating the Characteristics of Traditional Chinese Medicine".
    "Several Policy Measures for Development" were released on November 23, 2019 and January 22, 2021.
    From the context of the development of these three policies, it is not difficult to see that Chinese medicine is from top to bottom, from macro to micro, and from the system.
    At the local level, policy dividends are being released step by step
    .
     
      The "Opinions" is divided into six parts and a total of 15 articles.
    Among them, the benefits of Chinese medicine are reflected in the fixed-point inclusion of medical insurance, the price of Chinese medicine services, the scope of medical insurance payment, and the payment policy
    .
     
      Among them, the "Opinions" clearly pointed out that general TCM medical service items can continue to be paid by item, and TCM medical institutions may temporarily not implement DRG payment.
    For areas that have implemented DRG and disease-based payment, appropriately increase TCM medical institutions and TCM diseases.
    The coefficients and scores of these categories fully reflect the characteristics and advantages of traditional Chinese medicine services
    .
     
      As the current medical insurance payment reform is gradually shifting from the project system to the prepayment system, and the coexistence of multiple payment methods such as disease type, DRG/DIP, etc.
    , according to the characteristics of Chinese medicine, the policy of continuing to pay by project and not implementing DRG payment for the time being can be It is said that a separate "safe haven" has been opened, which is very beneficial to the development of Chinese medicine
    .
     
      According to the Fourteenth Five-Year Plan and the three-year action plan, by the end of 2024, all coordinated areas across the country will carry out the DRG/DIP payment method reform; by the end of 2025, the DRG/DIP payment method will cover all eligible medical institutions that provide hospitalization services.
    Basically achieve full coverage of disease types and medical insurance funds
    .
    Among them, the comprehensive coverage of disease types (in principle, 90%), the annual progress should be no less than 70%, 80%, and 90% respectively.
    The start-up area in 2024 must be completed within two years
    .
    Encourage the enrollment rate to reach more than 90%; after that, a list of 32 DRG/DIP paid demonstration sites was announced
    .
     
      There is also a special payment policy for the dominant diseases of traditional Chinese medicine
    .
     
      The "Opinions" can pay per bed day for the dominant Chinese medicine diseases that require long-term hospitalization, such as rehabilitation medical treatment and tranquility treatment
    .
    Explore the long-term treatment cycle, controllable risks, and need continuous treatment of TCM diseases, carry out day TCM medical services, implement disease-based payment, reasonably determine the payment standard, and the country will uniformly formulate a list of disease types in day wards
    .
    For the compact county medical community led by traditional Chinese medical institutions, the total budget is appropriately tilted
    .
     
      The "Opinions" clarified that public medical institutions purchase Chinese herbal medicines from formal channels, and sell them in strict accordance with the actual purchase price plus no more than 25%
    .
    Correspondingly, Western medicines and consumables have already implemented zero-addition, which is in sharp contrast
    .
    The "Opinions" also encourage the inclusion of traditional Chinese medicine formula granules purchased by public medical institutions into online transactions on the provincial centralized pharmaceutical procurement platform to promote openness and transparency of transactions
    .
     
      In addition, with regard to the medical insurance catalog, the adjustment authority of the national version of the catalog has long been withdrawn to the National Bureau, and the original local supplements will soon be digested.
    However, the local medical insurance department still retains the adjustment authority of ethnic medicine, medical preparations and traditional Chinese medicine
    .
     
      The "Opinions" clearly pointed out that all localities should include eligible ethnic medicines, traditional Chinese medicine preparations in medical institutions and Chinese herbal medicines into the scope of local medical insurance payments according to procedures according to fund affordability and clinical needs, and establish a dynamic adjustment mechanism
    .
     
    Chinese herbal medicines   that comply with the "Prescription Management Measures" and the " Management Standards of Chinese Herbal Medicines in Hospitals " but exceed the usual dose prescribed in the "Pharmaccopoeia of the People's Republic of China" will be included in the scope of medical insurance payment
    .
    It can be said that as far as possible , Chinese medicine- related products and services are included in the scope of payment, which greatly enhances the development space of Chinese medicine
    .
    Hospital Hospital Hospital Chinese Medicine Chinese Medicine Chinese Medicine
     
      In recent years, with the legislation of the "Traditional Chinese Medicine Law", the "Opinions of the Central Committee of the Communist Party of China and the State Council on Promoting the Inheritance and Innovative Development of Traditional Chinese Medicine" and the "Several Policy Measures of the General Office of the State Council on Accelerating the Development of Traditional Chinese Medicine", the Chinese medicine industry It has been highly valued by the country
    .
    The outstanding performance of Chinese medicine during the new crown pneumonia epidemic has also won the recognition of the whole society
    .
     
      At the same time, Chinese patent medicines have gradually entered the scope of mass procurement following the pace of chemical medicines
    .
     
      On December 27th, Hubei led the 19 provinces leading Chinese patent medicine inter-provincial alliance and announced the results of the centralized procurement of Chinese patent medicines
    .
    A total of 157 companies and 182 products in the 17 product groups of the procurement catalog participated in the quotation, with a procurement scale of nearly 10 billion yuan
    .
    In the end, 97 companies and 111 products were selected, with a selection rate of 62%.
    The average price of the selection dropped by 42.
    27%, and the largest drop was 82.
    63%
    .
    According to the calculation of the annual demand of the 19 provincial alliances, it is estimated that more than 2.
    6 billion yuan of drug costs can be saved each year
    .
    Enterprise enterprise enterprise medicine medicine medicine
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.